Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pullar

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depressionLorraine Axford, John R Boot, Terrence M Hotten, et al.
European Journal of Pharmacology|December 6, 2001
In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist propertiesI A Pullar, J R Boot, S L Carney, et al.
Annals of Surgical Oncology|June 24, 2024
ASO Author Reflections: The Role of Postoperative Radiation Therapy Following Wide Excision of Neurotropic Melanoma of the Head and Neck: Now and into the FutureM B Pinkham, A Herschtal, A M Hong, et al.
Annals of Surgical Oncology|June 8, 2024
Randomized Trial of Postoperative Radiation Therapy After Wide Excision of Neurotropic Melanoma of the Head and Neck (RTN2 Trial 01.09)Mark B Pinkham, A Herschtal, A M Hong, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depressionLorraine Axford, John R Boot, Terrence M Hotten, et al.
European Journal of Pharmacology|December 6, 2001
In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist propertiesI A Pullar, J R Boot, S L Carney, et al.
Annals of Surgical Oncology|June 24, 2024
ASO Author Reflections: The Role of Postoperative Radiation Therapy Following Wide Excision of Neurotropic Melanoma of the Head and Neck: Now and into the FutureM B Pinkham, A Herschtal, A M Hong, et al.
Annals of Surgical Oncology|June 8, 2024
Randomized Trial of Postoperative Radiation Therapy After Wide Excision of Neurotropic Melanoma of the Head and Neck (RTN2 Trial 01.09)Mark B Pinkham, A Herschtal, A M Hong, et al.
Pageof 5